Sagefield Capital’s Apollo Endosurgery, Inc. APEN Stock Holding History

Sagefield Capital’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-154,500	Closed	-$1.53M	–	114
2023 Q1	$1.53M	Buy	+154,500	New	+$1.53M	0.35%	54

Sagefield Capital's APEN Position: Q2 2023 in Review

Sagefield Capital sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 154,500 shares — an estimated $1.53M sold.

Sagefield Capital first reported a position in APEN in Q1 2023 and held it in 1 quarter. The position peaked at $1.53M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Sagefield Capital reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Sagefield Capital sold 154,500 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $1.53M.
Sagefield Capital first reported a position in Apollo Endosurgery, Inc. in Q1 2023 and held it in 1 quarter.
Sagefield Capital's Apollo Endosurgery, Inc. position peaked at $1.53M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Sagefield Capital's 13F filing for Q2 2023, filed 14 Aug 2023.